• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普萘洛尔对急性心肌梗死的保护作用。

Protective effect of propranolol in threatened myocardial infarction.

作者信息

Norris R M, Clarke E D, Sammel N L, Smith W M, Williams B

出版信息

Lancet. 1978 Oct 28;2(8096):907-9. doi: 10.1016/s0140-6736(78)91628-8.

DOI:10.1016/s0140-6736(78)91628-8
PMID:81925
Abstract

Propranolol 0.1 mg/kg intravenously followed by 320 mg orally over 27 h was given to 20 randomly selected patients within 4 h of the onset of suspected myocardial infarction unaccompanied by diagnostic electrocardiographic changes. Patients given propranolol had fewer completed infarcts as assessed by serial electrocardiograms, a lower frequency of serum-creatine-kinase levels above the normal range, and lower peak serum-creatine-kinase levels than 23 control subjects. This evidence suggests that threatened myocardial infarction can in some cases be prevented by early beta-adrenoceptor blockade.

摘要

在疑似心肌梗死发作后4小时内,对20例随机选择的患者静脉注射0.1mg/kg普萘洛尔,随后在27小时内口服320mg,这些患者未伴有诊断性心电图改变。通过系列心电图评估,接受普萘洛尔治疗的患者梗死灶形成较少,血清肌酸激酶水平高于正常范围的频率较低,且血清肌酸激酶峰值水平低于23例对照受试者。这一证据表明,在某些情况下,早期β-肾上腺素能受体阻滞剂可预防心肌梗死的发生。

相似文献

1
Protective effect of propranolol in threatened myocardial infarction.普萘洛尔对急性心肌梗死的保护作用。
Lancet. 1978 Oct 28;2(8096):907-9. doi: 10.1016/s0140-6736(78)91628-8.
2
Reduction of enzyme levels by propranolol after acute myocardial infarction.急性心肌梗死后普萘洛尔降低酶水平。
Circulation. 1978 Jun;57(6):1091-5. doi: 10.1161/01.cir.57.6.1091.
3
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial.普萘洛尔对心肌梗死面积的影响:一项随机双盲多中心试验
N Engl J Med. 1984 Jul 26;311(4):218-25. doi: 10.1056/NEJM198407263110403.
4
Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course.
Circulation. 1986 Jun;73(6):1281-90. doi: 10.1161/01.cir.73.6.1281.
5
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol.
Lancet. 1984 Oct 20;2(8408):883-6. doi: 10.1016/s0140-6736(84)90651-2.
6
Myocardial infarction in the dog: effects of intravenous propranolol.犬心肌梗死:静脉注射普萘洛尔的作用
Am J Cardiol. 1980 Apr;45(4):769-74. doi: 10.1016/0002-9149(80)90120-4.
7
Propranolol in acute myocardial infarction: the MILIS experience.普萘洛尔治疗急性心肌梗死:MILIS研究经验
Am J Cardiol. 1986 Apr 25;57(12):38F-42F. doi: 10.1016/0002-9149(86)90887-8.
8
Reduction of infarct size with the early use of timolol in acute myocardial infarction.
N Engl J Med. 1984 Jan 5;310(1):9-15. doi: 10.1056/NEJM198401053100103.
9
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS).透明质酸酶对血浆肌酸激酶MB早期峰值及非透壁性缺血患者死亡率和发病率的影响。梗死面积限制多中心研究(MILIS)。
Br Heart J. 1988 Oct;60(4):290-8. doi: 10.1136/hrt.60.4.290.
10
Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment.静脉注射普萘洛尔治疗人类急性心肌梗死:血流动力学及系列肌酸激酶评估
Chest. 1981 Mar;79(3):277-85. doi: 10.1378/chest.79.3.277.

引用本文的文献

1
Beta-blockers for suspected or diagnosed acute myocardial infarction.用于疑似或确诊急性心肌梗死的β受体阻滞剂。
Cochrane Database Syst Rev. 2019 Dec 17;12(12):CD012484. doi: 10.1002/14651858.CD012484.pub2.
2
Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism.急性危重病中的 shock induced endotheliopathy (SHINE) - 一种统一的病理生理学机制。
Crit Care. 2017 Feb 9;21(1):25. doi: 10.1186/s13054-017-1605-5.
3
Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.
急性冠状动脉综合征患者早期静脉内使用β受体阻滞剂——随机试验的荟萃分析。
Int J Cardiol. 2013 Sep 30;168(2):915-21. doi: 10.1016/j.ijcard.2012.10.050. Epub 2012 Nov 17.
4
Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.心脏性猝死与β-肾上腺素能受体阻滞剂的潜在作用
Postgrad Med J. 1993 Dec;69(818):903-11. doi: 10.1136/pgmj.69.818.903.
5
Free radical scavenging properties of beta-adrenoceptor blockers are not relevant for cardioprotection in isolated rabbit hearts.β-肾上腺素能受体阻滞剂的自由基清除特性与离体兔心脏的心脏保护作用无关。
Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):431-4. doi: 10.1007/BF00171344.
6
Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts.普萘洛尔治疗急性心肌梗死。对梗死进展期治疗组和对照组患者酶出现情况及随后左心室功能的进一步研究。
Br Heart J. 1980 Jun;43(6):617-22. doi: 10.1136/hrt.43.6.617.
7
Comparison of enzymic with cineangiocardiographic estimations of myocardial infarct size.心肌梗死面积的酶学测定与心血管造影测定的比较。
Br Heart J. 1980 Jun;43(6):609-16. doi: 10.1136/hrt.43.6.609.
8
Increased plasma propranolol binding in myocardial infarction.心肌梗死时血浆中普萘洛尔结合率升高。
Br J Clin Pharmacol. 1980 Apr;9(4):438-40. doi: 10.1111/j.1365-2125.1980.tb01077.x.
9
Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.阿普洛尔治疗66岁以下患者时对心肌梗死面积的限制作用。
Br Heart J. 1981 May;45(5):583-8. doi: 10.1136/hrt.45.5.583.
10
Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.在英国、意大利和南斯拉夫的49家医院进行的普萘洛尔心肌梗死后多中心试验。
Br Heart J. 1980 Jul;44(1):96-100. doi: 10.1136/hrt.44.1.96.